{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T23:21:47Z","timestamp":1782688907761,"version":"3.54.5"},"reference-count":109,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jaad.2023.12.077","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T16:30:14Z","timestamp":1709310614000},"page":"1051-1066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inflammatory and vaso-occlusive ulcers: Part II - Management"],"prefix":"10.1016","volume":"91","author":[{"given":"Alexander","family":"Hines","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Kody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadir","family":"Shakshouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Fett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex G.","family":"Ortega-Loayza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jaad.2023.12.077_bib1","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/bjd\/ljac137","article-title":"Features that define clinical severity of ulcerative pyoderma gangrenosum: a Delphi consensus study of experts and patients on behalf of the US Medical Dermatology Society","volume":"188","author":"Pimentel","year":"2023","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2023.12.077_bib2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s40257-022-00699-8","article-title":"Pyoderma gangrenosum: an updated literature review on established and emerging pharmacological treatments","volume":"23","author":"Maronese","year":"2022","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2023.12.077_bib3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1177\/1203475418782140","article-title":"Evaluating the efficacy of topical dapsone treatment for pyoderma gangrenosum: a retrospective case series","volume":"22","author":"Li","year":"2018","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.077_bib4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/iwj.13067","article-title":"Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: a semi-systematic review","volume":"16","author":"Ben Abdallah","year":"2019","journal-title":"Int Wound J"},{"issue":"5","key":"10.1016\/j.jaad.2023.12.077_bib5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/1346-8138.16337","article-title":"Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: final analysis of a 52-week phase 3 open-label study","volume":"49","author":"Yamasaki","year":"2022","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2023.12.077_bib6","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1080\/09546634.2021.1937475","article-title":"Ustekinumab as adjuvant treatment for all pyoderma gangrenosum subtypes","volume":"33","author":"Westerdahl","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2023.12.077_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jdcr.2021.11.030","article-title":"Modified dose of guselkumab for treatment of pyoderma gangrenosum","volume":"21","author":"Reese","year":"2022","journal-title":"JAAD Case Rep"},{"issue":"4","key":"10.1016\/j.jaad.2023.12.077_bib8","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/iwj.13359","article-title":"Successful treatment of a refractory pyoderma gangrenosum with risankizumab","volume":"17","author":"Burgdorf","year":"2020","journal-title":"Int Wound J"},{"key":"10.1016\/j.jaad.2023.12.077_bib9","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2147\/CCID.S374534","article-title":"Recalcitrant ulcerative pyoderma gangrenosum of the leg responsive to tildrakizumab: a case report","volume":"15","author":"Leow","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2023.12.077_bib10","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/ced.14809","article-title":"Anakinra for recalcitrant pyoderma gangrenosum","volume":"46","author":"O'Connor","year":"2021","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2023.12.077_bib11","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/bjd.14037","article-title":"Canakinumab in adults with steroid-refractory pyoderma gangrenosum","volume":"173","author":"Kolios","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2023.12.077_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jdcr.2023.01.022","article-title":"Spesolimab use in treatment of pyoderma gangrenosum","volume":"34","author":"Gu\u00e9nin","year":"2023","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaad.2023.12.077_bib14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jdcr.2022.10.001","article-title":"Treatment of pyoderma gangrenosum with apremilast monotherapy","volume":"30","author":"Bordeaux","year":"2022","journal-title":"JAAD Case Rep"},{"issue":"6","key":"10.1016\/j.jaad.2023.12.077_bib15","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/ced.14683","article-title":"Tofacitinib for the treatment of refractory pyoderma gangrenosum","volume":"46","author":"Orfaly","year":"2021","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2023.12.077_bib16","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/ddg.14716","article-title":"Response of rheumatoid arthritis-associated pyoderma gangrenous to the JAK1 inhibitor upadacitinib","volume":"20","author":"Kooybaran","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2023.12.077_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2021.100099","article-title":"Successful treatment of ulcerated pyoderma gangrenosum with baricitinib, a novel JAK inhibitor","volume":"4","author":"Scheinberg","year":"2021","journal-title":"J Transl Autoimmun"},{"issue":"4","key":"10.1016\/j.jaad.2023.12.077_bib18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40257-014-0076-6","article-title":"A practical approach to the diagnosis, evaluation, and management of cutaneous small-vessel vasculitis","volume":"15","author":"Goeser","year":"2014","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2023.12.077_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40257-022-00736-6","article-title":"Cutaneous small vessel vasculitis: a practical guide to diagnosis and management","volume":"24","author":"Micheletti","year":"2023","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.12.077_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2020.104033","article-title":"Management of cutaneous vasculitis","volume":"49","author":"Micheletti","year":"2020","journal-title":"Presse Med"},{"issue":"2 Pt 1","key":"10.1016\/j.jaad.2023.12.077_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0190-9622(85)70158-2","article-title":"Colchicine is effective in controlling chronic cutaneous leukocytoclastic vasculitis","volume":"13","author":"Callen","year":"1985","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2023.12.077_bib22","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/00007611-198707000-00012","article-title":"Cutaneous leukocytoclastic vasculitis: clinical experience in 44 patients","volume":"80","author":"Callen","year":"1987","journal-title":"South Med J"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.077_bib23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0002-9343(96)00405-6","article-title":"Clinical features and outcome of 95 patients with hypersensitivity vasculitis","volume":"102","author":"Martinez-Taboada","year":"1997","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.jaad.2023.12.077_bib24","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0190-9622(87)70100-5","article-title":"Sulfone therapy in the treatment of leukocytoclastic vasculitis. Report of three cases","volume":"16","author":"Fredenberg","year":"1987","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2023.12.077_bib25","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/archdermatol.2011.3037","article-title":"Treatment of severe cutaneous small-vessel vasculitis with mycophenolate mofetil","volume":"148","author":"Haeberle","year":"2012","journal-title":"Arch Dermatol"},{"issue":"8895","key":"10.1016\/j.jaad.2023.12.077_bib26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(94)92746-4","article-title":"Synergistic effects of pentoxifylline and dapsone in leucocytoclastic vasculitis","volume":"343","author":"N\u00fcrnberg","year":"1994","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jaad.2023.12.077_bib27","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1001\/archderm.142.11.1407","article-title":"Successful use of rituximab for cutaneous vasculitis","volume":"142","author":"Chung","year":"2006","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.077_bib28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jaad.2004.01.003","article-title":"Therapy for severe necrotizing vasculitis with infliximab","volume":"51","author":"Mang","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.077_bib29","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1365-2133.2000.03681.x","article-title":"Successful treatment of chronic leucocytoclastic vasculitis and persistent ulceration with intravenous immunoglobulin","volume":"143","author":"Ong","year":"2000","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.077_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1468-3083.1996.tb00156.x","article-title":"Cyclosporin A in the treatment of cutaneous vasculitis. Clinical and cellular effects","volume":"6","author":"Tosca","year":"1996","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2023.12.077_bib31","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1001\/archderm.1991.04510010083008","article-title":"Azathioprine. An effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis","volume":"127","author":"Callen","year":"1991","journal-title":"Arch Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2023.12.077_bib32","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archderm.1995.01690240061009","article-title":"Colchicine in the treatment of cutaneous leukocytoclastic vasculitis. Results of a prospective, randomized controlled trial","volume":"131","author":"Sais","year":"1995","journal-title":"Arch Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2023.12.077_bib33","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1136\/annrheumdis-2016-209133corr1","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis [published correction appears in","volume":"76","author":"Yates","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.jaad.2023.12.077_bib34","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/art.41773","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.jaad.2023.12.077_bib35","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the treatment of ANCA-associated vasculitis","volume":"384","author":"Jayne","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.077_bib36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/art.41943","article-title":"Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study","volume":"74","author":"Bettiol","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10.1016\/j.jaad.2023.12.077_bib37","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1136\/annrheumdis-2021-220484","article-title":"Tofacitinib for the treatment of antineutrophil cytoplasm antibody-associated vasculitis: a pilot study","volume":"80","author":"Liu","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.jaad.2023.12.077_bib38","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1093\/rheumatology\/keab916","article-title":"Obinutuzumab as\u00a0treatment for ANCA-associated vasculitis","volume":"61","author":"Amudala","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.jaad.2023.12.077_bib39","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/art.41774","article-title":"2021 American College of Rheumatology\/Vasculitis foundation guideline for the management of giant cell arteritis and Takayasu arteritis","volume":"73","author":"Maz","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.077_bib40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/jamadermatol.2017.4374","article-title":"Treatment for livedoid vasculopathy: a systematic review","volume":"154","author":"Micieli","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2023.12.077_bib41","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/j.1468-3083.2010.03646.x","article-title":"Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs--a prospective study","volume":"24","author":"Di Giacomo","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2023.12.077_bib42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000246113","article-title":"Low-dose danazol in the treatment of livedoid vasculitis","volume":"194","author":"Hsiao","year":"1997","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.jaad.2023.12.077_bib43","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archderm.1986.01660130070028","article-title":"Livedoid vasculitis and central nervous system involvement in systemic lupus erythematosus","volume":"122","author":"Yasue","year":"1986","journal-title":"Arch Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2023.12.077_bib44","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0025-6196(12)60922-7","article-title":"Tissue plasminogen activator for treatment of livedoid vasculitis","volume":"67","author":"Klein","year":"1992","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.077_bib45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1365-4362.2001.01183.x","article-title":"Livedoid vasculitis responding to PUVA therapy","volume":"40","author":"Lee","year":"2001","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2023.12.077_bib46","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/09546634.2020.1737634","article-title":"Efficacy of an anti-TNF-alpha agent in refractory livedoid vasculopathy: a retrospective analysis","volume":"33","author":"Gao","year":"2022","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"10.1016\/j.jaad.2023.12.077_bib47","first-page":"84","article-title":"Livedoid vasculitis (segmental hyalinizing vasculitis)","volume":"82","author":"Winkelmann","year":"1972","journal-title":"Jpn J Dermatol B"},{"issue":"5","key":"10.1016\/j.jaad.2023.12.077_bib48","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/jamadermatol.2022.0241","article-title":"Treatment of livedoid vasculopathy with baricitinib","volume":"158","author":"Song","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.077_bib49","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000246335","article-title":"Successful treatment of livedo vasculitis with beraprost sodium: a possible mechanism of thrombomodulin upregulation","volume":"192","author":"Tsutsui","year":"1996","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.jaad.2023.12.077_bib50","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0190-9622(82)70123-9","article-title":"Antiplatelet therapy in atrophie blanche and livedo vasculitis","volume":"7","author":"Drucker","year":"1982","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2023.12.077_bib51","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1001\/archderm.1988.01670050028013","article-title":"Livedo vasculitis. Therapy with pentoxifylline","volume":"124","author":"Sams","year":"1988","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2023.12.077_bib52","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jaad.2013.07.019","article-title":"Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach","volume":"69","author":"Alavi","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"5Part A","key":"10.1016\/j.jaad.2023.12.077_bib53","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ijwd.2021.08.013","article-title":"Livedoid vasculopathy: a multidisciplinary clinical approach to diagnosis and management","volume":"7","author":"Bilgic","year":"2021","journal-title":"Int J Womens Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2023.12.077_bib54","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1111\/jdv.17613","article-title":"Real-world data on pain management and effectiveness of anti-tumour necrosis factor agents in refractory livedoid vasculopathy","volume":"36","author":"Gao","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2023.12.077_bib55","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-000924","article-title":"Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"5","author":"Tektonidou","year":"2019","journal-title":"RMD Open"},{"issue":"22","key":"10.1016\/j.jaad.2023.12.077_bib56","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.jaad.2023.12.077_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-228403","article-title":"Pyoderma gangrenosum-like lesion secondary to methylenetetrahydrofolate reductase mutation: an unusual presentation of a rare disease","volume":"12","author":"Turkowski","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jaad.2023.12.077_bib58","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/VHRM.S175150","article-title":"Cholesterol-embolization syndrome: current perspectives","volume":"15","author":"Ozkok","year":"2019","journal-title":"Vasc Health Risk Manag"},{"issue":"7","key":"10.1016\/j.jaad.2023.12.077_bib59","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ajh.24745","article-title":"Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia","volume":"92","author":"Sidana","year":"2017","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.jaad.2023.12.077_bib60","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jaad.2021.10.063","article-title":"Calciphylaxis: treatment and outlook-CME part II","volume":"86","author":"Rick","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2023.12.077_bib61","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/CWCMR.S172427","article-title":"Martorell ulcer: chronic wound management and rehabilitation","volume":"6","author":"Mansour","year":"2019","journal-title":"Chron Wound Care Manag Res"},{"issue":"Sup6","key":"10.1016\/j.jaad.2023.12.077_bib62","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.12968\/jowc.2019.28.Sup6.S1","article-title":"Atypical wounds. Best clinical practice and challenges","volume":"28","author":"Isoherranen","year":"2019","journal-title":"J Wound Care"},{"issue":"1","key":"10.1016\/j.jaad.2023.12.077_bib63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1742-481x.2004.00008.x","article-title":"Wound bed advisory board members. Wound bed preparation and a brief history of TIME","volume":"1","author":"Schultz","year":"2004","journal-title":"Int Wound J"},{"issue":"5","key":"10.1016\/j.jaad.2023.12.077_bib64","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1524-475X.2000.00347.x","article-title":"Classifications for wound bed preparation and stimulation of chronic wounds","volume":"8","author":"Falanga","year":"2000","journal-title":"Wound Repair Regen"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.077_bib65","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/wrr.12994","article-title":"Chronic wounds: treatment consensus","volume":"30","author":"Eriksson","year":"2022","journal-title":"Wound Repair Regen"},{"issue":"9","key":"10.1016\/j.jaad.2023.12.077_bib66","article-title":"Debridement for venous leg ulcers","volume":"2015","author":"Gethin","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.jaad.2023.12.077_bib67","doi-asserted-by":"crossref","first-page":"398","DOI":"10.12968\/jowc.2019.28.6.398","article-title":"Effects of a surfactant-based gel on acute and chronic paediatric wounds: a panel discussion and case series","volume":"28","author":"Kirsner","year":"2019","journal-title":"J Wound Care"},{"key":"10.1016\/j.jaad.2023.12.077_bib68","series-title":"Local Wound Care for Dermatologists. Updates in Clinical Dermatology","first-page":"35","article-title":"The use of antiseptic and antibacterial agents on wounds and the skin","author":"Maliyar","year":"2020"},{"key":"10.1016\/j.jaad.2023.12.077_bib69","series-title":"Local Wound Care for Dermatologists. Updates in Clinical Dermatology","first-page":"25","article-title":"Wound dressings","author":"Weir","year":"2020"},{"issue":"9","key":"10.1016\/j.jaad.2023.12.077_bib70","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jamadermatol.2013.4960","article-title":"Frequency of debridements and time to heal: a retrospective cohort study of 312 744 wounds","volume":"149","author":"Wilcox","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.077_bib71","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/bjd.21612","article-title":"Challenges in the diagnosis and management of wound infection","volume":"187","author":"Malone","year":"2022","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.077_bib72","doi-asserted-by":"crossref","first-page":"275e","DOI":"10.1097\/PRS.0000000000008142","article-title":"Biofilm management in wound care","volume":"148","author":"Sen","year":"2021","journal-title":"Plast Reconstr Surg"},{"issue":"12","key":"10.1016\/j.jaad.2023.12.077_bib73","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1089\/wound.2020.1168","article-title":"A wound care specialist's approach to pyoderma gangrenosum","volume":"9","author":"Croitoru","year":"2020","journal-title":"Adv Wound Care"},{"issue":"4","key":"10.1016\/j.jaad.2023.12.077_bib74","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7603\/s40681-015-0022-9","article-title":"Wound dressings - a review","volume":"5","author":"Dhivya","year":"2015","journal-title":"Biomedicine (Taipei)"},{"issue":"18","key":"10.1016\/j.jaad.2023.12.077_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202203233","article-title":"Smart dual-sensor wound dressing for monitoring cutaneous wounds","volume":"12","author":"Mirani","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.jaad.2023.12.077_bib76","first-page":"ic44","article-title":"Severe bilateral lower extremity pyoderma gangrenosum","volume":"16","author":"Laun","year":"2016","journal-title":"Eplasty"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.077_bib77","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/cod.13044","article-title":"Allergic contact dermatitis caused by acrylic-based medical dressings and adhesives","volume":"79","author":"Mestach","year":"2018","journal-title":"Contact Dermatitis"},{"issue":"4","key":"10.1016\/j.jaad.2023.12.077_bib78","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3400\/avd.ra.12.00068","article-title":"Compression therapy: clinical and experimental evidence","volume":"5","author":"Partsch","year":"2012","journal-title":"Ann Vasc Dis"},{"issue":"6","key":"10.1016\/j.jaad.2023.12.077_bib79","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/iwj.12012","article-title":"Chronic leg ulcers in adult patients with rheumatological diseases - a 7-year retrospective review","volume":"11","author":"Chia","year":"2014","journal-title":"Int Wound J"},{"key":"10.1016\/j.jaad.2023.12.077_bib80","first-page":"4","volume":"5","author":"Dini","year":"2016","journal-title":"Compression in vasculitis. Veins and Lymphatics"},{"issue":"3","key":"10.1016\/j.jaad.2023.12.077_bib81","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1365-4362.2002.01373_1.x","article-title":"Pathergic pyoderma gangrenosum in a venous ulcer","volume":"41","author":"Rosina","year":"2002","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2023.12.077_bib82","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2230.1993.tb01027.x","article-title":"Pyoderma gangrenosum--a complication of chronic venous leg ulceration?","volume":"18","author":"Harland","year":"1993","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2023.12.077_bib83","doi-asserted-by":"crossref","first-page":"844","DOI":"10.12659\/AJCR.908995","article-title":"Improvement of ulcerations in treatment-resistant chronic scarring in a patient with pyoderma gangrenosum after improving vascular insufficiency, gently removing necrotic debris, and decreasing wound fluid","volume":"19","author":"Nahm","year":"2018","journal-title":"Am J Case Rep"},{"issue":"4","key":"10.1016\/j.jaad.2023.12.077_bib84","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1742-481X.2011.00899.x","article-title":"Prevalence of immune disease in patients with wounds presenting to a tertiary wound healing centre","volume":"9","author":"Shanmugam","year":"2012","journal-title":"Int Wound J"},{"key":"10.1016\/j.jaad.2023.12.077_bib85","series-title":"Local Wound Care for Dermatologists. Updates in Clinical Dermatology","first-page":"83","article-title":"Compression therapy","author":"Mervis","year":"2020"},{"issue":"12","key":"10.1016\/j.jaad.2023.12.077_bib86","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/01.ASW.0000720264.41419.38","article-title":"Evaluation of longitudinal and tubular compression treatment for lower limb edema","volume":"33","author":"Sibbald","year":"2020","journal-title":"Adv Skin Wound Care"},{"issue":"9","key":"10.1016\/j.jaad.2023.12.077_bib87","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jamadermatol.2013.4959","article-title":"Frequent debridement for healing of chronic wounds","volume":"149","author":"Lebrun","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.12.077_bib88","first-page":"44","article-title":"A post-hoc analysis of reduction in diabetic foot ulcer size at 4 weeks as a predictor of healing by 12 weeks","volume":"56","author":"Snyder","year":"2010","journal-title":"Ostomy Wound Manage"},{"issue":"7 Suppl","key":"10.1016\/j.jaad.2023.12.077_bib89","doi-asserted-by":"crossref","first-page":"239S","DOI":"10.1097\/01.prs.0000222891.74489.33","article-title":"Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial","volume":"117","author":"Sheehan","year":"2006","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jaad.2023.12.077_bib90","series-title":"Local Wound Care for Dermatologists. Updates in Clinical Dermatology","first-page":"107","article-title":"Negative pressure wound therapy","author":"Dini","year":"2020"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.077_bib91","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/bjd.20772","article-title":"Wound healing: potential therapeutic options","volume":"187","author":"Bosanquet","year":"2022","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.077_bib92","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/wrr.12884","article-title":"Hyperbaric oxygen therapy for nonhealing wounds: treatment results of a single center","volume":"29","author":"Teguh","year":"2021","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.jaad.2023.12.077_bib93","series-title":"Local Wound Care for Dermatologists. Updates in Clinical Dermatology","first-page":"113","article-title":"Oxygen therapy in wound healing","author":"Barysch","year":"2020"},{"issue":"5","key":"10.1016\/j.jaad.2023.12.077_bib94","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/wrr.12594","article-title":"Hierarchical evaluation of electrical stimulation protocols for chronic wound healing: an effect size meta-analysis","volume":"25","author":"Khouri","year":"2017","journal-title":"Wound Repair Regen"},{"issue":"4","key":"10.1016\/j.jaad.2023.12.077_bib95","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1590\/abd1806-4841.20142519","article-title":"Effects of low-power light therapy on wound healing: LASER x LED","volume":"89","author":"Chaves","year":"2014","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jaad.2023.12.077_bib96","series-title":"Local Wound Care for Dermatologists. Updates in Clinical Dermatology","first-page":"129","article-title":"Stem cell therapy in wound care","author":"Aljghami","year":"2020"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.077_bib97","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/wrr.12882","article-title":"Efficacy and safety of skin grafting in treatment of vasculitic ulcer and\u00a0pyoderma gangrenosum-A systematic review","volume":"29","author":"Morgenstjerne-Schwenck","year":"2021","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.jaad.2023.12.077_bib98","author":"Snyder","year":"2020"},{"key":"10.1016\/j.jaad.2023.12.077_bib99","series-title":"Local Wound Care for Dermatologists. Updates in Clinical Dermatology","first-page":"139","article-title":"Cellular- and acellular-based therapies; skin substitutes and matrices","author":"Cahn","year":"2020"},{"issue":"7","key":"10.1016\/j.jaad.2023.12.077_bib100","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.burns.2018.02.029","article-title":"Skin xenotransplantation: historical review and clinical potential","volume":"44","author":"Yamamoto","year":"2018","journal-title":"Burns"},{"issue":"12","key":"10.1016\/j.jaad.2023.12.077_bib101","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.36849\/JDD.2020.5306","article-title":"Use of topical timolol maleate as Re-epithelialization agent for treatment of recalcitrant wounds of varying etiologies","volume":"19","author":"Cahn","year":"2020","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.12.077_bib102","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jaad.2022.02.021","article-title":"Topical timolol enhances surgical wound healing in the lower portion of the leg in older patients with comorbidities: a retrospective review","volume":"87","author":"Manci","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.12.077_bib103","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100717RR","article-title":"Beta adrenergic receptor antagonist can modify Pseudomonas aeruginosa biofilm formation in\u00a0vitro: implications for chronic wounds","volume":"36","author":"Medina Lopez","year":"2022","journal-title":"FASEB J"},{"issue":"11","key":"10.1016\/j.jaad.2023.12.077_bib104","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1089\/wound.2019.0970","article-title":"Absorption and safety of topically applied timolol for treatment of chronic cutaneous wounds","volume":"8","author":"Gallegos","year":"2019","journal-title":"Adv Wound Care"},{"issue":"10","key":"10.1016\/j.jaad.2023.12.077_bib105","first-page":"967","article-title":"Pain and pain management in dermatology","volume":"13","author":"Beiteke","year":"2015","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"10.1016\/j.jaad.2023.12.077_bib106","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/08941939.2020.1821134","article-title":"5% lidocaine hydrochloride cream for wound pain relief: a multicentre observational study","volume":"35","author":"Janowska","year":"2022","journal-title":"J Invest Surg"},{"issue":"10","key":"10.1016\/j.jaad.2023.12.077_bib107","first-page":"S1","article-title":"Wound care centers: critical thinking and treatment strategies for wounds","volume":"28","author":"de Leon","year":"2016","journal-title":"Wounds"},{"issue":"1","key":"10.1016\/j.jaad.2023.12.077_bib110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000519503","article-title":"Malnutrition in obesity: is it possible?","volume":"15","author":"Kobyli\u0144ska","year":"2022","journal-title":"Obes Facts"},{"issue":"2","key":"10.1016\/j.jaad.2023.12.077_bib111","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.clindermatol.2021.10.002","article-title":"Nutrition and cutaneous wound healing","volume":"40","author":"Grada","year":"2022","journal-title":"Clin Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2023.12.077_bib112","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.pmr.2022.06.007","article-title":"Nutrition and wound care","volume":"33","author":"Munoz","year":"2022","journal-title":"Phys Med Rehabil Clin N Am"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224004249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224004249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T07:49:47Z","timestamp":1732088987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962224004249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":109,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0190962224004249"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2023.12.077","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory and vaso-occlusive ulcers: Part II - Management","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2023.12.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2024.01.083","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}